



Roehrich et al., J Stem Cell Res Ther 2012, S9
http://dx.doi.org/10.4172/2157-7633.S9-002
J Stem Cell Res Ther                                                                                                                            ISSN:2157-7633  JSCRT, an open access journal Cardiac Resident Stem Cells & Progenitors
Characterization of Cardiac-derived Myelo-monocytoid Progenitor Cells
Marc-Estienne Roehrich1, Lucio Barile2, Albert Spicher1, Mauro Giacca3 and Giuseppe Vassalli1,2*
1Department of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland
2Molecular Cardiology Laboratory, Fondazione Cardiocentro Ticino, Lugano, Switzerland
3International Center for Genetic Engineering and Biotechnology, Trieste, Italy
*Corresponding authors: Giuseppe Vassalli, Cardiology, Department of 
Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV), University of 
Lausanne, Lausanne, Switzerland, E-mail: giuseppe.vassalli@chuv.ch 
Marc-Estienne Roehrich, Department of Cardiology, Centre Hospitalier 
Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland, 
E-mail: marc-estienne.roehrich@chuv.ch 
Received April 30, 2012; Accepted June 22, 2012; Published June 24, 2012
Citation: Roehrich ME, Barile L, Spicher A, Giacca M, Vassalli G (2012) 
Characterization of Cardiac-derived Myelo-monocytoid Progenitor Cells. J Stem 
Cell Res Ther S9:002. doi:10.4172/2157-7633.S9-002
Copyright: © 2012 Roehrich ME, et al. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited.
Abstract
Cells migrating from heart tissue biopsies during ex vivo culture have been associated with cardiomyogenic 
and angiogenic potential. We have characterized cells shed by murine cardiac explants cultured in MesenCult 
MSC medium. A relatively uniform population with a distinguishable morphology emerged from the early cellular 
outgrowth. This population expressed monocyte/macrophage and hematopoietic markers (CD11b+, CD14+, CD45+) 
but neither mesenchymal (CD90–, CD105–) nor endothelial (CD31–) markers. It was maintained in culture with a stable 
phenotype for more than 10 months. When cultured in differentiation medium, cells expressed cardiac sarcomeric 
α-actinin. They spontaneously formed sphere clusters (“cardiospheres”). This process was enhanced by TNFα. 
Spheres from neonatal mice exhibited spontaneous beating. To assess whether “contaminating” myocardial tissue 
fragments would explain CS beating, neonatal Z/EG transgenic mice were injected with an adeno-associated virus 
(AAV) vector expressing Cre-recombinase from a cardiac-specific promoter (Ncx1), resulting in the excision of a lacZ 
gene and activatation of the expression of the second reporter gene, enhanced green fluorescent protein (EGFP). 
Cardiac explants from Z/EG mice receiving AAV-9.Ncx1-CRE expressed EGFP, whereas the cellular outgrowth 
did not, demonstrating that the presence of cardiomyocytes in the outgrowth was not required for the generation 
of cardiac progenitor cells. Whether the myelo-monocytoid population originated from a retained hematologic 
component of explants or cardiac-resident leukocytes remains unclear. These results are in line with recent data on 
monocyte-derived multipotent cells (MOMC) with cardiomyogenic potential. They suggest that the cardiac-derived 
myelo-monocytoid cell, although not considered a classical adult progenitor cell, may have regenerative potential.
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Introduction
Over the past decade, accumulating evidence has suggested that 
the adult mammalian heart may harbor one or more populations of 
progenitor cells endowed with regenerative potential [1]. Whether 
these cells represent adult cardiac-resident progenitor cells (CPCs) or 
bone marrow (BM)-derived cells homing to the heart is incompletely 
understood. We and others have shown that BM-derived cells can 
acquire stem cell properties in the damaged heart [2,3]. At minimum, 
5 seemingly different populations of cardiac stem cells have been 
described [4]. Whether these populations represent distinct entities 
of cardiac stem cells or different developmental and/or physiological 
stages of a single entity of stem cell remains unclear.
For the prospective isolation of CPCs, many studies have 
relied upon specific antibodies that recognize cell-surface antigen 
markers expressed by stem cells in other tissues, and particularly 
by hematopoietic stem cells, such as c-kit (CD117; stem cell factor 
receptor) [5] and stem cell antigen-1 (Sca-1) [6]. However, no single 
cell surface marker definitely identifies a single entity of CPC.
Alternatively, progenitor cells have been obtained from heart tissue 
biopsies maintained in primary culture [7-14]. Cells shed by cardiac 
explants in primary culture initially form a layer of fibroblast-like cells 
on which numerous small round ‘‘phase-bright” cells appear with a 
delay of 1 to 2 weeks [11]. The cellular outgrowth from murine neonatal 
cardiac explants is heterogeneous and includes both hematopoietic 
(CD45+) and non-hematopoietic (CD45– ) cells. The hematopoietic 
component of the cellular outgrowth can be minimized by perfusing 
the heart with heparinized saline before placing the tissue explant in 
culture [12]. This observation suggests that CD45+ cells in the cellular 
outgrowth may originate from a retained hematologic component. 
The cellular outgrowth from saline-perfused hearts displayed a 
heterogeneous immunophenotype consistent with a mixed population 
of CPCs (differentiation lineage-negative [Lin–], c-kit+), endothelial 
cells (CD31+, CD34+), and mesenchymal/stromal cells (CD90+, 
CD105+), but not hematopoietic cells (CD45–).
Cells shed by cultured cardiac explants from rodents and humans 
can form multicellular sphere clusters, or “cardiospheres” (CS). CS 
formation is associated with an increase in progenitor cells, endothelial 
cells and mesenchymal cells but a decrease in hematopoietic cells 
[1,12,13]. It has been suggested that human CS may result from stem 
cells endowed with cardiomyogenic and angiogenic potential [12,13]. 
In animal models of myocardial infarction, CS as well as CS-derived 
cells injected intramyocardially enhanced blood vessel formation and 
functional recovery. However, a recent study challenged the view 
that CS from rodents are a source of stem cells with cardiomyogenic 
potential [14]. This study claimed that beating CS were explained by 
“contaminating” myocardial tissue fragments that detached from the 
explants as these became less cohesive after extended periods of time 
in culture. Removing cell aggregates with filters minimized CS beating. 
This issue remains controversial [14]. Here, we have isolated, expanded 
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and characterized cells shed by cardiac explants from neonatal or 
adult mice in primary culture. We consistently obtained a relatively 
uniform cell population with a distinguishable morphology, which 
expressed monocyte/macrophage and hematopoietic markers, but 
neither endothelial nor MSC markers (with the exception of CD44). 
These myelo-monocytoid cells grew slowly but could be maintained in 
culture with a stable phenotype for more than 10 months. Cells from 
neonatal mice, but not those from adult mice, formed spontaneously 
beating CS. To assess whether “contaminating” myocardial tissue 
fragments could explain CS beating, we used the Z/EG double-reporter 
system. Cardiac-specific expression of Cre-recombinase resulted in 
the excision of a lacZ gene and activation of expression of the second 
reporter gene (enhanced green fluorescent protein; EGFP) in the heart 
of Z/EG transgenic mice. After Cre-recombinase gene transfer, EGFP 
expression was observed in Z/EG heart tissue explants but not in the 
cellular outgrowth, demonstrating that the presence of cardiomyocytes 
in the outgrowth was not required for the generation of CPC. These 
findings suggest that myelo-monocytoid cells isolated from cardiac 
explant outgrowths may be of potential interest as a cell source for 
cardiac repair.
Materials and Methods
Cell isolation and culture
Hearts were collected from neonatal (1-2 days of age) or adult (8-
10 weeks of age) male C57Bl/6 mice (Charles River Labs, France). The 
neonatal heart was rinsed abundantly with ice-cold heparinized saline 
and ventricles were cut into small pieces that were placed in Corning 
Costar 6-well plates (Sigma) with no extracellular matrix (ECM) 
protein coating. The adult heart was retrogradely perfused with ice-cold 
heparinized saline and ventricles were cut into small pieces that were 
incubated with 5 mL RPMI supplemented with 12.5 µL Liberase II and 
25 µL DNAse I (both from Roche) for 30 min at 37°C (this treatment 
was performed because of the higher ECM content of the adult heart 
compared with the neonatal). Tissue pieces were placed in 5.5-cm 
(Greiner) or 10 cm plastic dishes (Sarstedt) with no extracellular matrix 
(ECM) protein coating. Cardiac explants were cultured in MesenCult 
medium consisting of MesenCult MSC Basal Medium supplemented 
with serum-containing MesenCult MSC Stimulatory Supplements 
(both from Stem Cell Technologies). After 2 weeks, tissue explants 
were removed from the plates or dishes, and the cellular outgrowth was 
allowed to grow as a plastic-adherent monolayer. When cells reached 
near-confluence, they were detached from plastic with PBS-EDTA, 
collected, and seeded onto new plates.
Flow cytometric analyses
For flow cytometric analysis, cells were gently detached from 
plastic with PBS-EDTA, filtered through a 70-µm filter, centrifuged, 
and resuspended in reagent A Leucoperm B4FO9B (AbD Serotec) for 
15 min at RT. Then, they were washed in PBS, centrifuged, resuspended 
in reagent B, incubated with primary antibody (Supplementary Table 
1) for 30 min at RT, washed with PBS and, when necessary, labeled with 
Alexa 488 (Invitrogen; 1:25 dilution) for 30 min at RT. Flow cytometric 
analysis was performed using a FACSCalibur system (BD Bioscience) 
and the CellQuest software. Gates used to resolve antigen-expressing 
cells were set using appropriate isotype-specific control antibodies.
Differentiation media
To induce cardiac differentiation, adherent cells were grown 
in MesenCult medium for 2-3 months and then transferred 
to differentiation medium consisting of MesenCult medium 
supplemented with 1.3 µM dexamethasone, 50 µg/mL ascorbic 
acid, and 10 mM glycerol-2 phosphate for 14 days [15]. To induce 
adipogenic differentiation, cells were transferred to MesenCult 
medium supplemented with 1.3 µM dexamethasone.
Immunocytochemistry
Immunohistochemistry was performed as previously described 
[15]. Briefly, cells were seeded on Lab-Tek Chamber-Slides (Nunc) 
and fixed with 4% paraformaldheyde (PFA). For immunostaining of 
sarcomeric α-actinin, a monoclonal anti-α-actinin sarcomeric antibody 
(Sigma; 1:750 dilution) labeled with Alexa 488 (Invitrogen; 1:400 
dilution) was used. For immunostaining of α-smooth muscle actin 
(α-SMA), a rabbit polyclonal anti-α-SMA antibody (Abcam; 1:750 
dilution) labeled with Alexa 594 (Invitrogen; 1:400 dilution) was used. 
Nuclei were stained with DAPI. CS were stained with anti-tubulin A 
antibody labeled with Alexa 488, and nuclei were stained with Hoechst 
dye (1:1000 dilution).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total mRNA was extracted using the RNeasy Mini kit (Qiagen), as 
described [15]. The different cDNAs were generated using the Quanti-
tect reverse transcription kit (Qiagen) on 500 ng total RNA, with a ge-
nomic DNA digestion step. The cDNA was then used for quantification 
using the Quantitect SYBR Green PCR Kit (Qiagen) and the Rotor-
Gene 2000 (Qiagen). Quantitative PCRs were set up in 10 mL reaction 
volume with 5 mL of Quantimix, 0.5 mL of 10 mM forward primer, 0.5 
mL of 10 mM reverse primer, 3 mL cDNA, and 1 mL water. The poly-
merase was heat-activated for 15min at 95°C. The reactions were then 
cycled 50 times (948C, 15 s; 508C, 30 s; 728C, 30s) followed by a melt-
ing step. The following primers were used for SYBR Green real-time 
PCR: GATA4, fw: 50-ccccaatctcgatatgtttga-30, rev: 50-atggccccacaatt-
gaca-30; cardiac α-actinin, fw: 50-gctgctccaactgaccctgtcc-30, rev: 50-cg-
gcccacgatggacgggaa-30; GAPDH, fw: 50-tcaagaaggtggtgaagcag-30, rev: 
50-aagtggaagagtgggagtt-30. Relative expression was calculated using 
the comparative DDCT method. GAPDH was used as a reference gene.
CS formation
To study CS formation, the explant outgrowth from neonatal or 
adult mice was cultured in MesenCult medium for 2 to 5 months. In a 
subset of experiments, MesenCult medium was changed to Dulbecco-
modified Eagle medium supplemented with 10% fetal calf serum 
(DMEM-10% FCS) to compare the two media in terms of CS formation. 
Moreover, the effect of cytokines and growth factors on CS formation 
was addressed by supplementing MesenCult medium with 5 ng/mL 
of tumor necrosis factor-α (TNF-α), bone morphogenetic proteins 
(BMP) 2 and 4, or transforming growth factor-β1 (TGFβ1), or with 
10 ng/mL of vascular endothelial growth factor-165 (VEGF165) or basic 
fibroblast growth factor (bFGF). In separate experiments, CS formed 
in MesenCult were transferred to low-serum medium consisting of 2 
volumes of B27-based medium (100 mL DMEM supplemented with 
Glutamax, 2 mL B27 50x [Gibco], and 1 mL penicillin/streptomycin/
fungizone 100x) and 1 volume of MesenCult medium. Cell cultures 
were monitored for the appearance of beating CS under the microscope. 
Epinephrine was used to test the responsiveness of CS beating rates to 
an adrenergic stimulus.
Experiments using Z/EG transgenic mice
To determine whether the cellular outgrowth from cardiac 
explants contained “contaminating” myocardial tissue fragments, we 
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used the Z/EG double-reporter system. In Z/EG transgenic mice, Cre-
recombinase (CRE) activity results in the excision of a lacZ reporter 
gene and the concomitant activation of the expression of enhanced 
green fluorescent protein (EGFP) as the second reporter gene [16]. 
Cardiac-specific expression of CRE was mediated by a serotype-9 
adeno-associated virus vector containing the Ncx1 promoter (AAV-9.
Ncx1-CRE). A vector containing a cytomegalovirus immediate-early 
promoter (AAV-9.CMV-CRE) was used as a control. AAV vectors 
were generated and characterized as described [17]. Vector stock titers 
ranged from 1 × 1012 to 1 × 1013 viral genome copies per milliliter. AAV 
vectors were injected intraperitoneally to neonatal mice anesthetized 
with 4% isoflurane. Green fluorescence in cardiac explants and cellular 
outgrowths was assessed by fluorescence microscopy.
Statistical analysis
The non-parametric Mann-Whitney-U test was used for 
comparisons between two groups. P < 0.05 was considered to be 
statistically significant.
Results
Cell isolation and culture
Cultured cardiac explants from neonatal or adult mice gave rise 
to cellular outgrowths becoming visible after 3-4 days. The early 
outgrowth was comprised of spindle-shaped cells and round, highly 
refringent (phase-bright) cells (Figure 1). Tissue explants were removed 
from culture after 2 weeks. After 4-6 weeks, cells from neonatal or 
adult mice acquired a relatively uniform, distinguishable morphology 
characterized by one or multiple, thin cytoplasmic processes (the 
compared the shape of cells with a single process to that of gingko 
biloba leaves; Figure 2). Cells grew slowly but could be maintained 
in culture for more than 10 months with a stable morphology and 
immunophenotype (see below).
Flow cytometric analyses
Flow cytometric analyses of cell surface antigens were performed 
on cardiac outgrowth-derived cells from neonatal mice (n = 5) after 2 
to 5 months in culture, as well as from adult mice (n = 3) after 2 to 9 
months in culture. Cells from neonatal or adult mice displayed similar 
cell-surface marker profiles (Figure 3). These were characterized by 
expression of monocyte/macrophage and hematopoietic markers 
Figure 1: Phase photomicrographs of a cardiac explant outgrowth. A. Low 
magnification view. B. High magnification view showing a heterogeneous cell 
morphology including both spindle-shaped and round cells.
Figure 2: Phase photomicrographs of cardiac outgrowth-derived cells from 
neonatal mice. A. High-magnification view showing the characteristic cell 
morphology with a broad cytoplasmic extension at one pole of the cell and a 
thin cytoplasmic process at the opposite pole. B. Gingko biloba leaf, to which 
the cell shape has been compared. C. Cells after 50 days in culture (arrow, 
elongated cell process; asterisks, cytoplasmic filaments apparently establishing 
intercellular contacts).
Figure 3: Flow cytometric analyses of cell-surface marker profiles of cardiac 
outgrowth-derived cells. A. Cells from neonatal mice. Flow cytometric plots from 
a representative analysis 5 months after cell isolation (two different antibodies 
were used for CD45 and CD11b analysis); bar histogram showing mean values 
(+ SD) from 5 independent analyses (2-5 months after cell isolation), excepted 
for ABCG2 and Sca-1 (1 analysis). B. Cells from adult mice. Flow cytometric 
plots from a representative analysis 9 months after cell isolation; bar histogram 
showing mean values (+ SD) from 3 independent analyses (2-9 months after cell 
isolation), excepted for ABCG2, NG2 and CD106 (1 analysis). C. Double-label 
analyses of CD45, CD14, c-kit, and Sca-1 expression.
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(CD11b, CD14, CD45), CD44 (considered a MSC and endothelial 
progenitor cell [EPC] marker), and NG2 proteoglycan (a marker of 
pericytes/perivascular cells and mesoangioblasts). Regarding stem cell-
associated markers, ATP-binding cassette G2 (ABCG2) was expressed 
by a significant subpopulation, CD133 was expressed by a subpopulation 
from neonatal but not adult mice, and Sca-1 was expressed by a larger 
subpopulation from adult compared with neonatal mice. The specificity 
of Sca-1 detection was tested using cells from Sca-1–deficient mice (data 
not shown). CD90 and CD105 (MSC markers), CD31 (an endothelial 
marker), CD34 (a hematopoietic and EPC marker), CD3e (T-cell 
receptor complex subunit), CD19, CD38 and CD45R (B-cell markers), 
CD49a, CD106 (vascular cell adhesion molecule-1; VCAM-1), Flk-1 
and major histocompatibility complex (MHC) class II molecules were 
essentially undetectable. Double-label analyses showed that c-kit+ 
cells and a majority of Sca-1+ cells were CD45+. To assess changes of 
the cell-surface marker profile over time, the same cell population 
from a neonatal heart was analyzed by flow cytometry after 2 and 5 
months (data are shown in Figure 4C and Figure 3A, respectively). 
Occasionally, cells lost their original morphology, enlarged, and ceased 
growth. To assess changes in cell-surface markers associated with 
morphological changes, we analyzed two subpopulations derived from 
the same population after 2 months inculture, the first one having 
partially lost the original morphology, and the second one having 
maintained it (Figure 4A and 4B, respectively). The subpopulation 
with altered morphology showed decreased percentages of CD11b+ and 
CD45+ cells but increased percentages of CD106+ cells compared with 
the subpopulation with unchanged morphology. These changes were 
paralled by increased mRNA expression of GATA-4 and sarcomeric 
α-actinin. These data suggest a shift from a hematopoietic to a non-
hematopoietic phenotype.
Cell differentiation potential
Cardiac outgrowth-derived cells cultured in cardiac differentiation 
medium stained positive for sarcomeric α-actinin (Figure 5), which 
appeared to be organized in microfibrils. A minority of cells stained 
positive for α -SMA. Cells cultured in Mesencult supplemented with 
1.3 µM dexamethasone enlarged and acquired intracellular droplets 
indicative of adipogogenic differentiation.
CS formation
Plastic-adherent outgrowth-derived cells from neonatal or adult 
mice spontaneously formed CS after 2 to 5 months in culture (Figure 
6). Neither low-adherence plates nor specific CS growth media were 
needed for CS formation. Mesencult medium was more efficient than 
DMEM-10% FCS in this regard. The effect of cytokines or growth 
factors, supplemented to Mesencult medium, on CS formation was 
evaluated. TNF-α significantly increased the number of CS. CS from 
neonatal, but not adult, mice occasionally exhibited spontaneous 
beating activity in MesenCult medium. Virtually all CS from neonatal 
mice exhibited spontaneous beating in low-serum B27-based medium 
(see: Supplementary electronic file S1). Beating activity lasted for 
several days to a few weeks. Epinephrine increased beating rates up to 
≈180 bpm.
Cell tracing using the Z/EG reporter system
To assess whether “contaminating” myocardial tissue fragments 
were responsible for CS beating, we used the double-reporter Z/EG 
system. Neonatal Z/EG cardiomyocytes transduced with AAV-9.
Ncx1-CRE or AAV-9.CMV-CRE in vitro were irreversibly labeled 
with EGFP (Figure 7). Neonatal cardiac fibroblasts transduced with 
AAV-9.CMV-CRE, but not those transduced with AAV-9. Ncx1-CRE, 
were similarly labeled. These data demonstrated cardiac-specific CRE 
expression using the Ncx1 promoter-containing vector. After 2 weeks 
in culture, heart tissue explants from neonatal Z/EG mice previously 
injected with AAV-9.Ncx1-CRE exhibited green fluorescence, whereas 
the cellular outgrowth did not, demonstrating lack of cardiomyocyte 
in the outgrowth.
Discussion
We have obtained a myelo-monocytoid cell population by 
outgrowth from murine cardiac explants maintained in primary tissue 
culture. This population exhibited a distinguishable morphology and 
could be maintained in culture for more than 10 months. The vast 
majority (≈ 80-90%) of cells expressed the leukocyte common antigen 
CD45, the monocyte/macrophage markers CD11b and CD14 [18-
20], CD44 (generally considered a mesenchymal and EPC marker, 
but not expressed by primary BM MSC and progenitor cells [21]), or 
the pericyte/perivascular cell marker NG2 [9,22,23]. Subpopulations 
expressed the stem cell-associated markers ABCG2, c-kit, and CD133 
Figure 4: Comparison of two subpopulations derived from the same cardiac 
outgrowth population from neonatal mice. After 2 months in culture, one 
subpopulation partially lost the original morphology (A), whereas the other 
maintained it (B). Flow cytometric analyses of cell-surface markers for the 
subpopulations with conserved (C) or altered (D) morphology (for comparison, 
flow cytometric data of the same population shown in panel C for the 2-month 
time point are shown in Figure 3A for the 5-month time point). (E) Double-label 
flow cytometric analyses of CD133, CD45, CD106 and CD44 expression in the 
subpopulation with conserved morphology. (F) qRT-PCR analysis of mRNA 
expression of GATA-4 and cardiac α-actinin (data are fold-increases in mRNA 
copy numbers for the subpopulation with altered morphology compared with that 
with conserved morphology).
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(the latter in cells from neonatal mice only). A small minority of 
cells expressed the endothelial marker CD31. Expression of the MSC 
markers CD90 and CD105 [24] was barely detectable. This cell-surface 
marker profile pointed to a myelo-monocytoid phenotype.
Monocyte-derived cells include macrophages, fibrocytes, dendritic 
cells, osteoclasts, and adipocytes [18-20]. Lack of expression of CD105 
by the isolated population suggested a monocytic phenotype, rather 
than a macrophage or fibrocytic [19]. Expression of NG2 proteoglycan 
has been observed on perivascular cells including pericytes and cardiac 
mesoangioblasts. The latter displayed cardiomyogenic potential [9]. 
Moreover, human MSC in multiple organs were shown to express NG2 
in vivo, thereby suggesting a perivascular origin of these cells [23]. In 
analogy to cardiac mesoangioblasts [9], the population isolated in the 
present study expressed NG2, CD44 and, in part, c-kit. On the other 
hand, it clearly differed from mesoangioblasts with respect to CD45, 
CD31, and CD34 expression.
Expression of CD44 by the isolated population may seem at odds 
with that of hematopoietic and monocytic markers. It should be noted, 
however, that blood monocyte-derived mesenchymal progenitors 
(MOMP) with mixed phenotypic features of monocytes, MSC, and 
endothelial cells have been described [25]. Moreover, MSC from BM 
and other tissues have been shown to express CD45 under certain 
conditions [26-29]. In some cases, CD45 expression by MSC was 
dramatically downregulated in culture [26,27]. Collectively, these data 
demonstrate the existence of CD45+ cells expressing mesenchymal 
markers, while also suggesting that certain CD45– populations 
expressing such markers may have originally been CD45+.
The myelo-monocytoid phenotype of the isolated population 
conflicted with published data. It should be emphasized that we used 
an unconventional protocol based on Mesencult medium, whereas 
Messina et al. [7] used an Iscove’s Modified Dulbecco’s Medium 
[IMDM]-based medium supplemented with 10% FCS. It has been 
shown that the composition of the culture medium alter the phenotype 
of cardiac outgrowth-derived cells [12]. Several groups independently 
reported that human cardiac outgrowths expressed MSC markers 
(CD90+, CD105+) but not hematopoietic markers (CD45–, CD34–, 
CD11b–, CD14–, CD19–) [10,13,30,31]. In rodents, cardiac outgrowths 
displayed a more heterogeneous phenotype. Andersen et al. [14] 
reported that rat cardiac outgrowths included fibroblasts, endothelial 
cells, EPCs, CD45– CS-forming cells, and CD45+ hematopoietic cells. 
Davis et al. [12] showed that retrograde perfusion of rat hearts with 
heparinized saline minimized the number of CD45+ cells in the cellular 
outgrowth. This was comprised of putative CPCs (c-kit+), endothelial 
cells and EPCs (CD31+, CD34+), and mesenchymal cells (CD90+). In 
the present study, perfusion of adult hearts with heparinized saline did 
not prevent the isolation of CD45+ cells. However, this observation 
does not rule out an origin of these cells from the retained hematologic 
component of cardiac explants. Incidentally, it should be mentioned 
that we were not able to isolate a similar cell population from mouse 
BM using the same culture conditions (data not shown). An alternate 
hypothesis is that the isolated population originated from cardiac-
resident leukocytes. In this regard, it has recently been shown that the 
unstressed mouse heart harbors 2.3 × 103 resident leukocytes/mg of 
tissue (as measured after heart perfusion according to Langendorff with 
an oxygenated medium for 5 minutes), the most prominent fraction 
being antigen-presenting mononuclear cells (CD11b+, CD11c+, F4/80+ 
and MHC-II+) followed by B-cells, monocytes, and T-cells [32].
Figure 5: Cardiac outgrowth-derived cells cultured in Mesencult for 2-3 months 
were transferred to cardiac or adipogenic differentiation media for 14 days. A. 
Immunostaining for sarcomeric α-actinin with Alexa 488 (green). Nuclei were 
stained with DAPI (blue). B. Immunostaining for α-SMA with Alexa 594 (red) 
and DAPI (blue). C. Merge. D/E. Phase photomicrographs of cardiac-derived 
cells showing adipogenic differentiation, as evidenced by intracytoplasmic fat 
droplets (low and high magnification views, respectively).
Figure 6: CS formation by cardiac outgrowth-derived cells from adult mice. A/B. 
Photomicrographs of CS (low and high magnification views, respectively). C. 
H&E staining of a CS section showing nuclei in the superficial layers as well as 
in the core. D. Immunostaining for tubulin A (green). E. Nuclear staining with 
Hoechst dye (nuclei). F. Merge. G. Effects of Mesencult medium supplementation 
with cytokines or growth factors on CS formation; DMEM-10% FCS was also 
tested for comparison (data are CS counts per well; *p < 0.05 vs. Mesencult).
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Regardless of whether the isolated population originated from 
blood cells trapped in the intravascular space of the explant or from 
cardiac-resident leukocytes, the high proportion of CD45+ and CD11b+ 
cells in the cultured population suggested an advantage for these cells 
in terms of survival or growth compared with other cells in the early 
outgrowth. Alternatively, these myelo-monocytoid cells might have 
resulted from the differentiation of progenitor cells. In either case, 
this outcome was unanticipated since MesenCult has been optimized 
for growth of MSC. Indeed, we previously showed that mouse cardiac 
MSC (Lin–, Sca-1+, CD90+, CD105+, CD45–, CD31–) could be expanded 
for more than 25 passages in MesenCult medium with a preserved 
immunophenotype [15].
Cardiac-derived myelo-monocytoid cells appeared to have 
cardiomyogenic potential. When cultured in differentiation 
medium, they stained positive for sarcomeric α-actinin. When 
cultured in MesenCult medium, they occasionally gave rise to free-
floating multicellular sphere clusters. This process was enhanced by 
TNF α. Sphere clusters were first described with neural stem cells 
(“neurospheres”) [33]. Spheres have been considered – or named, at 
least – a feature of stemness. It should be noter, however, that spheres 
may result from either cell proliferation or aggregation. Non-clonal 
spheres increase with increasing cell density in the culture plate, and 
therefore clonal sphere-formation assays need to be performed at very 
low cell densities, and ideally at the single-cell level [34]. In the present 
study, sphere formation was observed at relatively high cell densities, a 
possible hint to non-clonality. Previous studies indicated that human 
clonal CS resulted from stem cells with cardiomyogenic and angiogenic 
potential [12,13]. However, recent data in rodents questioned this 
notion [14]. Again, it is important to note methodological differences 
between our study and the original report by Messina et al. [7]. To induce 
CS formation, these investigators placed the cells in suspension culture 
in poly-D-lysine-coated plates in a base medium supplemented with 
bFGF, EGF, cardiotrophin-1, thrombin, and B27 as a serum substitute. 
In contrast, we observed CS formation from plastic-adherent cells (as 
opposed to suspension cultures) in MesenCult medium (as opposed to 
CS-forming medium).
The most obvious evidence of cardiomyogenic differentiation was 
the demonstration of beating. We occasionally observed spontaneous 
CS beating from neonatal mice in MesenCult medium. Virtually 
all spheres placed in a low-serum, B27-based medium showed 
Figure 7: Primary tissue culture from a neonatal Z/EG mouse heart. Upper left 
panel: Schematics of the Z/EG double reporter (lacZ, EGFP) system. Lower 
left panel: Tissue specificity of EGFP expression using AAV-9.Ncx1-CRE as 
compared with AAV-9.CMV-CRE. EGFP expression using the first vector was 
restricted to cardiomyocytes. Middle panel: Photomicrograph of Z/EG heart 
tissue explant and cell outgrowth. Right panel: Corresponding fluorescence 
photomicrograph (the boundaries of the tissue explant are indicated by a 
dashed line). Green fluorescence is detectable within the explant but not in the 
outgrowth.
spontaneous beating. Beating rates were responsive to an adrenergic 
stimulus, a feature of electrophysiologically mature cardiomyocytes.
Andersen et al. [14] recently suggested that CS beating from 
neonatal rodents might be explained by “contaminating” myocardial 
tissue fragments in the cellular outgrowth, especially when cardiac 
explants were not removed from culture plates. In the present 
study, tissue explants were removed from cultures after 2 weeks. In 
MesenCult medium, beating activity appeared 3 to 6 months after cell 
isolation. It seems unlikely that “contaminating” myocardial fragments 
would resume beating after such a long interval. To directly address 
this question, we used the Z/EG double-reporter system. Cardiac 
explants from neonatal Z/EG mice injected with the AAV-9.Ncx1-
CRE vector in vivo exhibited green fluorescence, whereas the cellular 
outgrowth did not. This observation demonstrated that the presence 
of cardiomyocytes in the cellular outgrowth was not required for the 
generation of CPC.
The theoretical possibility that cardiac-derived myelo-monocytoid 
cells originated from cardiac-resident MSC seems unlikely. Freisinger 
et al. [35] previously showed that clonally isolated, adipose tissue-
resident MSC (CD90+, CD105+, CD44+, CD4–, CD11b–, CD34–, CD45–, 
CD68–) cultured in various differentiation media (IL-1β, IL-3, M-CSF 
and MTG) differentiated into cells expressing early hematopoietic 
(c-kit) and monocyte/macrophage markers (CD11b). However, we did 
not use these differentiation media in the present study. Zhao et al. [36] 
described a subpopulation of adult pluripotent stem cells (PSC) from 
human peripheral blood monocytes, which in appearance resembled 
fibroblasts, expanded in the presence of M-CSF, expressed monocytic 
and hematopoietic markers (CD45, CD34, CD14), and could be induced 
to differentiate into various cell types in the presence of appropriate 
growth factors. Kuwana et al. [25,37] described human blood monocyte-
derived mesenchymal progenitors (MOMP) as well as monocyte-
derived multipotent cells (MOMC) expressing CD45, CD34, CD14 and 
type-I collagen. These cells showed a fibroblast-like morphology and 
mixed phenotypic features of monocytes, endothelial cells, and MSC. 
They contained progenitors with the capacity to differentiate into bone, 
cartilage, fat, skeletal and cardiac muscle, neuron, and endothelium 
[25,37-39]. Romagnani et al. [40] described clonogenic, multipotent, 
circulating CD14+CD34low cells that proliferated in response to stem 
cell growth factors. Our data on myelo-monocytoid cells obtained by 
outgrowth from from cardiac explants are in line with these reports 
on multipotent monocytes. These findings suggest that the monocyte, 
traditionally viewed as a committed precursor for macrophages and 
dendritic cells, may have a larger differentiation potential. Further 
studies are warranted to compare the regenerative potential of cardiac-
derived myelo-monocytoid cells with that of other CPC populations in 
animal models of heart injury.
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